Abstract
Hyposmia is a common finding in Parkinson’s disease (PD) and is usually tested through the University of Pennsylvania Smell Identification Test (UPSIT). The aim of our study is to provide a briefer version of the Italian-adapted UPSIT test, able to discriminate between PD patients and healthy subjects (HS). By means of several univariate and multivariate (machine-learning-based) statistical approaches, we selected 8 items by which we trained a partial-least-square discriminant analysis (PLS-DA) and a decision tree (DT) model: class predictions of both models performed better with the 8-item version when compared to the 40-item version. An area under the receiver operating characteristic (AUC-ROC) curve built with the selected 8 odors showed the best performance (sensitivity 86.8%, specificity 82%) in predicting the PD condition at a cut-off point of ≤ 6. These performances were higher than those previously calculated for the 40-item UPSIT test (sensitivity 82% and specificity 88.2 % with a cut-off point of ≤ 21). Qualitatively, our selection contains one odor (i.e., apple) which is Italian-specific, supporting the need for cultural adaptation of smell testing; on the other hand, some of the selected best discriminating odors are in common with existing brief smell test versions validated on PD patients of other cultures, supporting the view that disease-specific odor patterns may exist and deserve a further evaluation.
Supplementary Information
The online version contains supplementary material available at 10.1007/s10072-022-06457-2.
Keywords: University of Pennsylvania Smell Identification Test, Smell impairment, Parkinson’s disease, Machine learning
Introduction
Hyposmia represents one of the most frequent non-motor symptoms in Parkinson’s disease (PD), affecting more than 90% of PD patients [1, 2]. It can be detected very early in the course of the disease, often before motor symptoms start [1]. For this reason, olfaction dysfunction has been proven to be a reliable, early predictive marker for PD, with smell evaluation testing being as sensitive as the gold standard instrumental investigation, i.e., single-photon emission computed tomography (SPECT) for dopamine transporter (DaT) study [3]. The University of Pennsylvania Smell Identification Test (UPSIT) is the most employed tool to detect olfactory dysfunction in PD patients, in both clinical and research settings [4]. It consists of 40 microencapsulated odorants which are released by scratching standardized odor-impregnated strips [5]. Its use has been validated across different cohorts worldwide [6–9], with cultural item adaptation. We have previously developed the Italian version of the UPSIT in which some odors that are virtually unknown to Italian subjects, such as cheddar cheese, gingerbread, and turpentine were replaced by other odors, validating it in healthy subjects [10] and in PD [7].
A number of briefer smell tests have been subsequently developed (for example, the brief smell identification test (B-SIT) [11] and its version adapted to PD, namely the BSIT-B [12]), with the aim of abbreviating and, thus, optimizing smell evaluation in the routine clinical practice. As reviewed by Morley et al., [13] they reached fairly good diagnostic performances when compared to the UPSIT test. However, not all of them have been validated on the PD population. Therefore, abbreviated versions of the UPSIT have been tested in several studies, with reasonable predictive performance for PD [13, 14]. As for the full-length, 40-item version of the UPSIT, cross-cultural adaptation of brief versions is necessary. Therefore, the aim of the current work is to develop an abbreviated version of the Italian-adapted UPSIT test. To this aim, we employed several univariate and multivariate (machine learning-based) statistical approaches in order to select the best items of the 40-item UPSIT in discriminating PD patients from healthy subjects (HS).
Materials and methods
Study population
The current work stems from a secondary analysis of data from our previous study validating the culturally adapted version of the 40-item UPSIT smell test for the Italian population [7], with enrollment performed prior to the Covid-19 pandemic outbreak, thus excluding the possibility of SARS-CoV-2 infection-related hyposmia. In brief, the study subjects consisted of PD patients, as diagnosed according to the UK Brain Bank Criteria [15], compared to HS. Exclusion criteria for patients and HS were as follows: dementia, active upper respiratory tract inflammation, history of diabetes, nose surgery, or head trauma. The exclusion criterion for HS was a history of neurologic and/or psychiatric disease. All subjects underwent olfaction evaluation under medical supervision through the Italian version of the 40-item UPSIT.
Statistical Analysis
Univariate analysis
Individual responses to each of the 40 items were recorded as correct or incorrect. In order to calculate the performance of an UPSIT odor subset, as predictive of PD diagnosis, we computed the discriminatory power of each odor in differentiating PD from HS using different statistical methods. First, we assessed the diagnostic performance of each item by calculating the correct/incorrect answer ratio for each class and p-values using the Fisher χ2 test. Secondly, we calculated diagnostic odds ratios for each item. Thirdly, we calculated the area under the receiver operating characteristic (AUC-ROC) curve for each item using the statistical software SPSS ver.26 (IBM Corp., Armonk, NY, USA).
Machine learning algorithms: logistic regression and linear discriminant analysis
The discriminatory power of each odor in differentiating PD from HS was also evaluated using multivariate (machine-learning-based) statistical models: logistic regression (LR) and linear discriminant analysis (LDA) [16, 17]. A Full explanation of the mathematical bases of these two models can be found in Supplementary Information (Online resource).
LR was performed using the MetaboAnalystR Package [18]. LDA was performed using the corresponding operator from RapidMiner v. 9.10 [19]. This operator needed no setting, so it was used as it is. UPSIT items were ranked according to their weight in discriminating the two classes.
UPSIT item selection
For each statistical model, we selected the top 12 items with the best discriminating performance. The UpSetR plot, which is a diagram to visualize intersections of multiple sets [20], was employed to aggregate these items in a combination matrix in order to show their simultaneous selection by several statistical approaches. The items which resulted as being selected by at least 4 out of 5 models were used to train a partial least square-discriminant analysis (PLS-DA) model [21], which is a supervised method that uses multivariate regression techniques to extract, via linear combinations of original variables (X, in our case, the best-selected odor items), the information that can predict class membership (Y, in our case, PD vs. HS). This PLS-DA model has then been submitted to a cross-validation process, by means of which we constructed a confusion matrix to synthetize correct and incorrect attributions. This was accompanied by diagnostic performance (in terms of sensitivity, specificity, negative and positive likelihood ratio, negative and positive predictive value, accuracy, AUCROC) calculation of item combinations (MetaboAnalystR Package) [18]. Also, a decision tree (DT) [22] was built with the same best-discriminating items and the related diagnostic performances were calculated. (RapidMiner 9.10). The concept behind DT functioning is explained in Supplementary Information (Online resource). DT was subjected to a cross-validation process similar to PLS-DA.
Finally, an AUCROC curve was build using the same best-discriminating items and cut-off points for assigning subjects to the PD group were calculated (SPSS ver. 26), the best threshold being evaluated using the Youden index [23].
Results
Demographic and clinical features of the studied populations
UPSIT examinations were obtained from a population of 68 PD patients and 61 healthy subjects [7]. The two populations were homogeneous in terms of age (61.8 ± 8.5 vs. 59.5 ± 8.5 for PD and subjects, respectively, p = 0.1), sex distribution (men/women distribution of 58.8%/41.2% for PD and 44.3%/55.7% for HS, p = 0.6), and smoking status (14.7% of PD smokers vs. 16.4% of HS smokers, p = 0.4). In the PD group, the mean Unified PD Rating Scale, motor sub-scale (UPDRSIII) value was 14.1 ± 6.4, and the mean Hoehn and Yahr stage was 1.6 ± 0.4. As expected, the mean 40-item UPSIT score was significantly lower in PD than in HS (16.8 ± 4.9 vs. 26.6 ± 507, p < 0.001).
Odor selection
Five different statistical ranking strategies were used in order to select the best discriminating odors. Supplementary Table 1a shows the top 12 items with the best discriminating performance for each statistical method. Their occurrence or co-occurrence in one or more feature selection strategies was evaluated by means of an UpSetR plot (see Fig.1). As a result, 4 odors (namely, coconut, apple, lilac, orange) were selected by 5 models, 4 odors (namely, motor oil, banana, clove, watermelon) were selected by 4 models, 4 odors (namely, onion, talc, walnut, rose) were selected by 3 models, and 9 odors (chewing-gum, leather, fruit juice, cinnamon, chocolate, diluent, pine, grape, soap) were selected by only 1 model. This resulted in 8 items selected by at least 4 statistical models, (see Fig. 1 and items in bold, supplementary Table 1a) which were used to build a PLS-DA model for prediction performance calculation. The 8-item performances were compared to the PLS-DA-based prediction performances of the 40-item odor set. As shown in Table 1, the 8-item odor subset outperformed the 40-item odor set in terms of sensitivity (82% vs. 79%), specificity (92% vs. 85%), positive likelihood ratio (10:05 vs. 5,38), negative likelihood ratio (0:19 v. 0:24), positive predictive value (92% vs. 86%), negative predictive value (82% vs. 79%), and accuracy (86% vs. 82%). Figure 2 compares PLS-DA-based AUCROC curves for the 8-item and the 40-item set (0.887 vs. 0.89 respectively). Two DTs were built employing and comparing the 8 best discriminating items and the whole set of 40 items. They are shown in supplementary Fig. 1 and 2 (Online resource). In both trees, item 7 (i.e., banana) represents the starting node, and item 8 (i.e., clove) represents the immediately subsequent node with a huge relevance if correctly identified, in PD exclusion. As secondary nodes, items 10 (i.e., coconut) and 30 (i.e., watermelon) are shared by both trees in having a certain relevance in discriminating PD from healthy subjects. The diagnostic performances of the two DTs are shown in Table 1. They are lower than those obtained with PLS-DA but again, the 8-item subset performs better than the whole odor set of 40 items with respect to sensitivity (72% vs. 65%), specificity (85% vs. 80%), positive likelihood ratio (4:88 vs. 3:29), negative likelihood ratio (0:33 vs. 0:44), positive predictive value (84% vs. 79%), negative predictive value (73% vs. 67%), and accuracy (78.3% vs. 72.1%).
Table 1.
PLS-DA based | DT based | |||
---|---|---|---|---|
8-item subset | 40-item set | 8-item subset | 40-item set | |
Sensitivity | 0.82 ± 0.05 | 0.79 ± 0.05 | 0.72 ± 0.05 | 0.65 ± 0.06 |
Specificity | 0.92 ± 0.04 | 0.85 ± 0.05 | 0.85 ± 0.05 | 0.80 ± 0.05 |
Positive likelihood ratio | 10.05 | 5.38 | 4.88 | 3.29 |
Negative likelihood ratio | 0.19 | 0.24 | 0.33 | 0.44 |
Negative predictive value | 0.82 ± 0.05 | 0.79 ± 0.05 | 0.73 ± 0.05 | 0.67 ± 0.05 |
Positive predictive value | 0.92 ± 0.04 | 0.86 ± 0.04 | 0.84 ± 0.05 | 0.79 ± 0.05 |
Accuracy | 0.868 | 0.822 | 0.783 | 0.721 |
Finally, the AUCROC curve built with the selected 8 odors (coconut, apple, lilac, orange, motor oil, banana, clove, watermelon) showed the best performance (sensitivity 86.8%, specificity 82%) in predicting the PD condition at a cut-off point of ≤ 6. These performances were higher than those calculated for the 40-item UPSIT test (sensitivity 82% and specificity 88.2 % with a cut-off point of ≤ 21) [7].
Discussion
In the present work, by means of several univariate and multivariate (machine learning) statistical algorithms, we selected the 8 best UPSIT items in discriminating PD patients from HS. Machine learning supervised approaches (in our case, PLS-DA and DT) were also employed to train and cross-validate models for PD vs. HS class prediction. These two statistical algorithms showed a better diagnostic performance when dealing with the selected 8 items than when dealing with the whole set of 40 odors. This is intrinsically related to machine learning behavior. Indeed, data dimension reduction, which means that the number of features (in our case, the UPSIT items) is limited with respect to the number of observations (in our case, subjects), makes the training of classifiers more effective and decreases overfitting occurrence [24]. Accordingly, one of the principal concepts (informally known as “garbage in garbage out”) of computer science is that the better the quality of input data, the better the output is [25].
In addition, a comparison of our short test with the leader short smell identification test among those validated for PD (i.e., the 12-item BSIT-B, as evaluated by Joseph et al. [14]), showed, at the best sensitivity/specificity combination, a much better specificity with a quite negligible difference in sensitivity (sensitivity/specificity of 86.8/82% with a cut-off point of ≤ 6 vs. 96.5/51.8% with a cut-off point of ≤ 9, respectively), which is valuable aiming to screen for PD among subjects who might have lower smell performance due to other reasons, including aging.
As highlighted in the introductory section, many efforts in selecting UPSIT odor subsets and in testing their ability in identifying PD subjects have been performed in other cultures. Our 8-item selection shares a few items with previously published works. Indeed, “orange” and “clove” were also selected by Joseph et al. [14], who chose 2 “winning” 7-items subsets of the UPSIT from all the possible combinations containing 1–7 smells. Moreover, “banana” and “motor oil” were also selected by Morley et al. [13], who chose the 12 best discriminating smells as selected from the UPSIT using a combination of different statistical ranking strategies. Furthermore, common items have been also identified with the BSIT-B test, namely “banana,” “clove,” and “coconut”[12]. The item “banana” was also identified as one of the best discriminating items between PD and HS by Bohnen et al. [26] and in a shorter 5-item version of the B-SIT test by Double et al. [27]. Also, this item was also selected, via the random forest machine-learning approach, as one of the three best PD vs. HS discriminating odors from the 16-item “Sniffin’ Sticks” test [28]. This aspect of common patterns in odor identification has raised the argument that there may be a selective hyposmia in PD [12], yet with conflicting results [29]. Indeed, “clove” was also selected in two studies aimed at finding UPSIT subsets able to predict Alzheimer’s disease, although the two selected subsets were not sufficiently consistent with each other [30, 31]. It should be also acknowledged that a qualitative comparison between previously developed abbreviated versions of the UPSIT is not entirely possible because of cultural adaptations: indeed, one of the items selected by our statistical model (i.e., “apple”), is Italian-specific and, as such, not present in the original UPSIT version; likewise, other odor sub-selections described in Morley et al. [13] and Joseph et al. [14] contain culturally specific items (i.e., items that have been substituted in the Italian UPSIT version). These are “root beer” and “gingerbread” in Joseph et al.[14] and “turpentine” in Morley et al. [13]. This raises concern about the fact that odor identification patterns in the available published cohorts might be, at least partially, dependent on cultural issues. This aspect might also explain the fact that the results obtained in the discovery cohort were not entirely confirmed when reassessed in an independent cohort [13]. More in general, however, the PD-predictive ability of 4 “cross-cultural” odors identified by Joseph et al. [14], was confirmed after validation on an independent, even though geographically linked, PD cohort [32], supporting the concept of a specific quality of smell dysfunction in PD.
A few studies have tried to look for distinctive patterns of smell impairment among hyposmic patients of various causes. A study by Hähner et al. [33] investigated PD patients in comparison to patients with smell loss from other causes, by using the 16-item “Sniffin’ Sticks” test; they found no differences in odor identification thresholds and patterns between the two populations. On the contrary, in a Japanese cohort of PD and post-viral hyposmic patients evaluated with the Open Essence test, two odors (namely, menthol and Indian Ink) were found to accurately differentiate the two cohorts of hyposmic patients [34]. These heterogenous findings remark on the need of obtaining culturally adapted versions of specific smell evaluation tests, the performances of which should be evaluated according to the specific research purpose. These tests might in fact be proven useful to discriminate between PD and hyposmic patients due to other reasons and/or to differentiate PD from other non-degenerative parkinsonian syndromes [35].
Conclusion
We have here presented an abbreviated 8-item UPSIT with a high accuracy in differentiating PD patients from healthy subjects, which makes smell evaluation much less time-consuming and feasible in routine clinical practice. We further showed that machine-learning-based odor selection is able to optimize this process, outperforming diagnostic performances of the full-length 40-item UPSIT. In this regard, however, we acknowledge a limitation of our study in the lack of validation on an independent PD cohort. Further studies are also warranted to explore whether the selected items are PD-specific by evaluating other populations affected by hyposmia due to other reasons and whether it accurately discriminates PD from other parkinsonian syndromes.
Supplementary Information
Funding
Open access funding provided by Università degli Studi di Salerno within the CRUI-CARE Agreement.
Declarations
Ethical approval
The study was approved by the local ethics committee.
Informed consent
Informed consent was obtained from patients or their family members including the consent of publication.
ᅟ
Conflict of interest
R.E. receives royalties from the publication of Case Studies in Movement Disorders—Common and Uncommon Presentations (Cambridge University Press, 2017) and of Paroxysmal Movement Disorders (Springer, 2020). He has received consultancies from Sanofi and honoraria for speaking from the International Parkinson’s Disease and Movement Disorders Society. P.B. received consultancies as a member of the advisory board for Zambon, Lundbeck, UCB, Chiesi, Abbvie, and Acorda. J.T. is employed in companies (Theoreo Srl and Hosmotic Srl) dealing with the development and market of machine-learning-based diagnostic tests. M.P. receives support from the Michael J Fox Foundation for Parkinson’s research. She has received consultancies from Abbvie and Zambon.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18:435–450. doi: 10.1038/nrn.2017.62. [DOI] [PubMed] [Google Scholar]
- 2.Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323:548–560. doi: 10.1001/jama.2019.22360. [DOI] [PubMed] [Google Scholar]
- 3.Deeb J, Shah M, Muhammed N, et al. A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson’s disease. QJM Mon J Assoc Physicians. 2010;103:941–952. doi: 10.1093/qjmed/hcq142. [DOI] [PubMed] [Google Scholar]
- 4.Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson’s disease: development of optimal discrimination criteria. Neurodegener J Neurodegener Disord Neuroprotection Neuroregeneration. 1995;4:93–97. doi: 10.1006/neur.1995.0011. [DOI] [PubMed] [Google Scholar]
- 5.Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984;94:176–178. doi: 10.1288/00005537-198402000-00004. [DOI] [PubMed] [Google Scholar]
- 6.Bohnen NI, Studenski SA, Constantine GM, Moore RY. Diagnostic performance of clinical motor and non-motor tests of Parkinson disease: a matched case-control study. Eur J Neurol. 2008;15:685–691. doi: 10.1111/j.1468-1331.2008.02148.x. [DOI] [PubMed] [Google Scholar]
- 7.Picillo M, Pellecchia MT, Erro R, et al. The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson’s disease in Italy. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2014;35:379–383. doi: 10.1007/s10072-013-1522-6. [DOI] [PubMed] [Google Scholar]
- 8.Campabadal A, Segura B, Baggio HC, et al. Diagnostic accuracy, item analysis and age effects of the UPSIT Spanish version in Parkinson’s disease. Arch Clin Neuropsychol Off J Natl Acad Neuropsychol. 2019;34:435–444. doi: 10.1093/arclin/acy053. [DOI] [PubMed] [Google Scholar]
- 9.Silveira-Moriyama L, de Carvalho MJ, Katzenschlager R, et al. The use of smell identification tests in the diagnosis of Parkinson’s disease in Brazil. Mov Disord Off J Mov Disord Soc. 2008;23:2328–2334. doi: 10.1002/mds.22241. [DOI] [PubMed] [Google Scholar]
- 10.Picillo M, Iavarone A, Pellecchia MT, et al. Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects. Clin Otolaryngol Off J ENT-UK Off J Neth Soc Oto-Rhino-Laryngol Cervico-Facial Surg. 2014;39:53–57. doi: 10.1111/coa.12212. [DOI] [PubMed] [Google Scholar]
- 11.Doty RL, Marcus A, Lee WW. Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT) Laryngoscope. 1996;106:353–356. doi: 10.1097/00005537-199603000-00021. [DOI] [PubMed] [Google Scholar]
- 12.Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1997;62:436–446. doi: 10.1136/jnnp.62.5.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Morley JF, Cohen A, Silveira-Moriyama L, et al. Optimizing olfactory testing for the diagnosis of Parkinson’s disease: item analysis of the University of Pennsylvania Smell Identification Test. NPJ Park Dis. 2018;4:2. doi: 10.1038/s41531-017-0039-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Joseph T, Auger SD, Peress L, et al. Screening performance of abbreviated versions of the UPSIT smell test. J Neurol. 2019;266:1897–1906. doi: 10.1007/s00415-019-09340-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988;51:745–752. doi: 10.1136/jnnp.51.6.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Stock JH, Watson MW. Introduction to Econometrics. III ed. Pearson; 2015. Regression with a binary dependent variable. [Google Scholar]
- 17.Xanthopoulos P, Pardalos PM, Trafalis TB (2013) Linear discriminant analysis. In: Robust data mining Springer:27–33
- 18.Pang Z, Chong J, Li S, Xia J. MetaboAnalystR 3.0: toward an optimized workflow for global metabolomics. Metabolites. 2020;10:10.3390/metabo10050186. doi: 10.3390/metabo10050186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Jungermann F (2009) Information extraction with rapidminer. Citeseer:50–61
- 20.Lex A, Gehlenborg N, Strobelt H, et al. UpSet: visualization of intersecting sets. IEEE Trans Vis Comput Graph. 2014;20:1983–1992. doi: 10.1109/TVCG.2014.2346248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Barker M, Rayens W. Partial least squares for discrimination. J Chemom. 2003;17:166–173. doi: 10.1002/cem.785. [DOI] [Google Scholar]
- 22.Breiman L, Friedman J, Stone CJ, Olshen RA (1984) Classification and regression trees. CRC press
- 23.Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J J Math Methods Biosci. 2005;47:458–472. doi: 10.1002/bimj.200410135. [DOI] [PubMed] [Google Scholar]
- 24.Chen R-C, Dewi C, Huang S-W, Caraka RE. Selecting critical features for data classification based on machine learning methods. J Big Data. 2020;7:52. doi: 10.1186/s40537-020-00327-4. [DOI] [Google Scholar]
- 25.Kilkenny MF, Robinson KM (2018) Data quality: “garbage in – garbage out.” Health Inf Manag J 47:103–105. 10.1177/1833358318774357 [DOI] [PubMed]
- 26.Bohnen NI, Gedela S, Kuwabara H, et al. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease. J Neurol. 2007;254:84–90. doi: 10.1007/s00415-006-0284-y. [DOI] [PubMed] [Google Scholar]
- 27.Double KL, Rowe DB, Hayes M, et al. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol. 2003;60:545–549. doi: 10.1001/archneur.60.4.545. [DOI] [PubMed] [Google Scholar]
- 28.Lo C, Arora S, Ben-Shlomo Y, et al. Olfactory testing in Parkinson disease and REM behavior disorder: a machine learning approach. Neurology. 2021;96:e2016–e2027. doi: 10.1212/WNL.0000000000011743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988;38:1237–1244. doi: 10.1212/wnl.38.8.1237. [DOI] [PubMed] [Google Scholar]
- 30.Woodward MR, Amrutkar CV, Shah HC, et al. Validation of olfactory deficit as a biomarker of Alzheimer disease. Neurol Clin Pract. 2017;7:5–14. doi: 10.1212/CPJ.0000000000000293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Tabert MH, Liu X, Doty RL, et al. A 10-item smell identification scale related to risk for Alzheimer’s disease. Ann Neurol. 2005;58:155–160. doi: 10.1002/ana.20533. [DOI] [PubMed] [Google Scholar]
- 32.Auger SD, Kanavou S, Lawton M, et al. Testing shortened versions of smell tests to screen for hyposmia in Parkinson’s disease. Mov Disord Clin Pract. 2020;7:394–398. doi: 10.1002/mdc3.12928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hähner A, Maboshe W, Baptista RB, et al. Selective hyposmia in Parkinson’s disease? J Neurol. 2013;260:3158–3160. doi: 10.1007/s00415-013-7153-2. [DOI] [PubMed] [Google Scholar]
- 34.Fujio H, Inokuchi G, Tatehara S, et al. Characteristics of Smell Identification Test in patients with Parkinson disease. Clin Exp Otorhinolaryngol. 2019;12:206–211. doi: 10.21053/ceo.2018.01116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Brigo F, Erro R, Marangi A, et al. Differentiating drug-induced parkinsonism from Parkinson’s disease: an update on non-motor symptoms and investigations. Parkinsonism Relat Disord. 2014;20:808–814. doi: 10.1016/j.parkreldis.2014.05.011. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.